Antimicrobial Armageddon: The Professional Guide to Conquering Antibiotic Resistance | Probiotics and Antimicrobial Proteins | Springer Nature Link Skip to main content Advertisement Log in Menu Find a journal Publish with us Track your research Search Saved research Cart Home Probiotics and Antimicrobial Proteins Article Antimicrobial Armageddon: The Professional Guide to Conquering Antibiotic Resistance Research Published: 20 February 2026 Volume 18 , pages 7304–7338 ( 2026 ) Cite this article Save article View saved research Probiotics and Antimicrobial Proteins Aims and scope Submit manuscript Alissar AlJerf ORCID: orcid.org/0009-0009-2218-8108 1 , Abdullah H. Maad ORCID: orcid.org/0000-0002-6009-5166 2 , Prince O. Ukaogo ORCID: orcid.org/0000-0001-8289-1764 3 , Loai Aljerf ORCID: orcid.org/0000-0002-1132-9659 4 , Atem Bethel Ajong ORCID: orcid.org/0000-0002-5513-2110 5 , 6 & … Muaaz Alajlani ORCID: orcid.org/0000-0001-9087-6863 7 Show authors 342 Accesses 5 Citations Explore all metrics Abstract Antibiotic resistance has accelerated into a critical global health emergency, undermining the effectiveness of modern medicine and increasing the burden of severe, persistent, and difficult-to-treat infections. This review synthesizes current evidence on the biological, clinical, and public health dimensions of resistance and highlights the major drivers behind its rapid expansion. Recent epidemiological data reveal substantial increases in mortality associated with resistant bloodstream, respiratory, and intra-abdominal infections, emphasizing the urgency of coordinated intervention. Mechanistic analyses demonstrate how horizontal gene transfer (HGT), mutational adaptation, biofilm formation, efflux systems, and enzymatic drug modification collectively strengthen bacterial survival. In parallel, persistent and tolerant cell populations further complicate therapeutic outcomes by enabling recurrent and chronic infections. Despite these challenges, several promising countermeasures have emerged. Advances in antimicrobial stewardship, drug repurposing, bacteriophage-based strategies, immunotherapies, and nanotechnology offer new avenues to restore or enhance antimicrobial efficacy. Innovative approaches—such as targeting novel metabolic pathways, disrupting virulence networks, and employing engineered phage systems—represent a growing frontier in drug development. Collectively, these insights highlight the importance of integrating molecular innovation, optimized clinical practices, and global surveillance as complementary strategies to mitigate the progression of antimicrobial resistance. Finally, this review acknowledges limitations related to the focus on bacterial pathogens, while recognizing that antifungal and antiviral resistance present parallel, distinct challenges in global health. This is a preview of subscription content, log in via an institution to check access. Access this article Log in via an institution Subscribe and save Springer+ from €37.37 /Month Starting from 10 chapters or articles per month Access and download chapters and articles from more than 300k books and 2,500 journals Cancel anytime View plans Buy Now Buy article PDF 39,95 € Price includes VAT (Italy) Instant access to the full article PDF. Institutional subscriptions Fig. 1 Fig. 2 Fig. 3 Fig. 4 Fig. 5 Fig. 6 Similar content being viewed by others Antimicrobial Resistance Paradigm and One-Health Approach Chapter © 2020 Global and Temporal Trends in the Use of Antibiotics and Spread of Antimicrobial Resistance Chapter © 2020 Antimicrobial Resistance Chapter © 2026 Explore related subjects Discover the latest articles, books and news in related subjects, suggested using machine learning. Antimicrobial Responses Antimicrobial therapy Antimicrobials Antibiotics Antimicrobial Resistance Antibacterial drug resistance Antimicrobial Resistance Mechanisms in Bacterial Systems Data Availability No data was used for the research described in the article. Abbreviations AA: amino acid AMPs: antimicrobial peptides AMR: antimicrobial resistance ATP: Adenosine Triphosphate BLI: β-Lactamase Inhibitor BSIs: Bloodstream Infections CDSS: Clinical Decision Support Systems ECDC: European Centre for Disease Prevention and Control CRE: carbapenem-resistant enterobacteriaceae CRISPR: Clustered Regularly Interspaced Short Palindromic Repeats DNA: Deoxyribonucleic Acid FA: fatty acid FDA: Food and Drug Administration FMT: Fecal Microbiota Transplantation HGT: Horizontal Gene Transfer MCMs: microbial cell membranes MDR: Multidrug-Resistant MDR-TB: multidrug-resistant tuberculosis MIC: Minimum Inhibitory Concentration MOs: Microorganisms MRSA: methicillin-resistant Staphylococcus aureus NGS: next-generation sequencing NPs: Nanoparticles PCR: Polymerase Chain Reaction PBP: Penicillin-Binding Protein RNA: Ribonucleic Acid TMP-SMX: trimethoprim and sulfamethoxazole WEF: World Economic Forum WGS: whole-genome sequencing WHO: World Health Organization References Aslam B, Wang W, Arshad MI, Khurshid M, Muzammil S, Rasool MH, Nisar MA, Alvi RF, Aslam MA, Qamar MU, Salamat MKF, Baloch Z (2018) Antibiotic resistance: a rundown of a global crisis. Infect Drug Resist 11:1645–1658. https://doi.org/10.2147/IDR.S173867 Article PubMed PubMed Central CAS Google Scholar Darby EM, Trampari E, Siasat P, Gaya MS, Alav I, Webber MA, Blair JMA (2023) Molecular mechanisms of antibiotic resistance revisited. Nat Rev Microbiol 21:280–295. https://doi.org/10.1038/s41579-022-00820-y Article PubMed CAS Google Scholar MacGowan A, Macnaughton E (2017) Antibiotic resistance. Med Baltim 45:622–628. https://doi.org/10.1016/j.mpmed.2017.07.006 Article Google Scholar Antimicrobial Resistance Collaborators (2022) Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399(10325):629–655. https://doi.org/10.1016/S0140-6736(21)02724-0 Article Google Scholar Brüssow H (2024) The antibiotic resistance crisis and the development of new antibiotics. Microb Biotechnol 17(7):e14510. https://doi.org/10.1111/1751-7915.14510 Article PubMed PubMed Central Google Scholar de Kraker ME, Stewardson AJ, Harbarth S (2016) Will 10 Million people die a year due to antimicrobial resistance by 2050? PLoS Med 13(11):e1002184. https://doi.org/10.1371/journal.pmed.1002184 Article PubMed PubMed Central Google Scholar Mickelsson M, Simbini T (2025) Health care integration for addressing antimicrobial resistance: traditional and conventional medical practices in AMR education. Glob Public Health 20(1):2579685. https://doi.org/10.1080/17441692.2025.2579685 Article PubMed Google Scholar Liu CSC, Pandey R (2024) Integrative genomics would strengthen AMR understanding through ONE health approach. Heliyon 10(14):e34719. https://doi.org/10.1016/j.heliyon.2024.e34719 Article PubMed PubMed Central CAS Google Scholar Chen W, Li L, Dai X, Feng L, Yu X (2025) Health risk and benefit assessment methods for antibiotic resistance bacteria/genes in the environment: a critical review. J Environ Manage 396:128071. https://doi.org/10.1016/j.jenvman.2025.128071 Article PubMed CAS Google Scholar Yan Y, Liu Z, Cao J, Fang J (2025) Mitigating antibiotic and antibiotic resistance gene contamination in animal manure compost by biochar: a review. Waste Management (New York, N.Y.) 210:115240. https://doi.org/10.1016/j.wasman.2025.115240 Article PubMed CAS Google Scholar Li J, Song J, Wang X, Li W, Han M, Li M, Wang S, Xu J, Zhang Q, Chen J, Cui S, Yang B (2025) Food-associated stressors and their synergistic roles in bacterial antibiotic resistance across the food supply chain. J Agric Food Chem 73(46):29310–29327. https://doi.org/10.1021/acs.jafc.5c10696 Article PubMed CAS Google Scholar Aslam B, Asghar R, Muzammil S, Shafique M, Siddique AB, Khurshid M, Ijaz M, Rasool MH, Chaudhry TH, Aamir A, Baloch Z (2024) AMR and sustainable development goals: at a crossroads. Global Health 20(1):73. https://doi.org/10.1186/s12992-024-01046-8 Article PubMed PubMed Central Google Scholar GBD 2023 Causes of Death Collaborators (2025) Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet 406(10513):1811–1872. https://doi.org/10.1016/S0140-6736(25)01917-8 Article Google Scholar Lee SJ, Yoon H, Shin JC, Cho SR (2026) Machine learning prediction of multidrug-resistant urinary tract infections in brain and spinal cord injury patients: a dual-center validation study. Int J Med Inform 206:106143. https://doi.org/10.1016/j.ijmedinf.2025.106143 Article PubMed Google Scholar Wang H, Ye C, Jiang H, Song R (2026) Application of next-generation sequencing in the detection of antimicrobial resistance. Clin Chim Acta 578:120520. https://doi.org/10.1016/j.cca.2025.120520 Article PubMed CAS Google Scholar Elbehiry A, Abalkhail A (2025) Metagenomic next-generation sequencing in infectious diseases: clinical applications, translational challenges, and future directions. Diagnostics Basel 15(16):1991. https://doi.org/10.3390/diagnostics15161991 Article PubMed PubMed Central CAS Google Scholar Abavisani M, Khoshrou A, Foroushan SK, Sahebkar A (2024) Chatting with artificial intelligence to combat antibiotic resistance: opportunities and challenges. Current Research in Biotechnology 7:100197 Article CAS Google Scholar Lai H, Ge L, Sun M, Pan B, Huang J, Hou L, Estill J (2024) Assessing the risk of bias in randomized clinical trials with large language models. JAMA Netw Open 7(5):e2412687–e2412687 Article PubMed PubMed Central Google Scholar Prasad M (2024) Introduction to the GRADE tool for rating certainty in evidence and recommendations. Clin Epidemiol Glob Health 25:101484 Article CAS Google Scholar Serwecińska L (2020) Antimicrobials and antibiotic-resistant bacteria: a risk to the environment and to public health. Water 12:3313. https://doi.org/10.3390/w12123313 Article CAS Google Scholar Ahmad M, Khan AU (2019) Global economic impact of antibiotic resistance: a review. J Glob Antimicrob Resist 19:313–316. https://doi.org/10.1016/j.jgar.2019.05.024 Article PubMed Google Scholar Bhattacharya R, Bose D, Gulia K, Jaiswal A (2024) Impact of antimicrobial resistance on sustainable development goals and the integrated strategies for meeting environmental and socio-economic targets. Environ Prog Sustain Energy 43(1):e14320 Article CAS Google Scholar Karnwal A, Jassim AY, Mohammed AA, Al-Tawaha ARMS, Selvaraj M, Malik T (2025) Addressing the global challenge of bacterial drug resistance: insights, strategies, and future directions. Front Microbiol 16:1517772 Article PubMed PubMed Central CAS Google Scholar Ali T, Habib A, Nazir Z, Ali M, Haque MA (2024) Healthcare challenges in lmics: addressing antibiotic resistance threats, a call for comprehensive global solutions: an editorial. Int J Surg 110(5):3085–3087 Article PubMed PubMed Central Google Scholar Killai SN (2024) Antibiotic resistance: strategies for combating the global threat. Medalion Journal: Med Res Nurs Health Midwife Participation 5(4):268–277 Google Scholar Pitiot A, Rolin C, Seguin-Devaux C, Zimmer J (2025) Fighting Antibiotic Resistance: insights into human barriers and new opportunities: Antibiotic Resistance constantly rises with the development of human activities. We discuss barriers and opportunities to get it under control. Bioessays 47(6):e70001 Article PubMed PubMed Central Google Scholar Chamas C (2025) Global commitment to combat antimicrobial resistance. Cad Saude Publica 41:e00190924 PubMed PubMed Central Google Scholar Nazir A, Nazir A, Zuhair V, Aman S, Sadiq SUR, Hasan AH, Bulimbe DB (2025) The global challenge of antimicrobial resistance: mechanisms, case studies, and mitigation approaches. Health Sci Rep 8(7):e71077 Article PubMed PubMed Central Google Scholar Nwakoby IP, Iheukwumere IH, Iheukwumere CM, Nwakoby NE, Idigo MA, Ike VE (2025) Antimicrobial resistance: a legal and public health perspective. IPS J Appl Microbiol Biotechnol 4(4):230–236 Article Google Scholar Ehsan H (2025) Antibiotic resistance in developing countries: emerging threats and policy responses. Public Health Challenges 4(1):e70034 Article Google Scholar Navidifar T, Zare Banadkouki A, Parvizi E, Mofid M, Golab N, Beig M, Sholeh M (2025) Global prevalence of macrolide-resistant Staphylococcus spp.: a comprehensive systematic review and meta-analysis. Front Microbiol 16:1524452 Article PubMed PubMed Central CAS Google Scholar Li J, Cheng F, Wei X, Bai Y, Wang Q, Li B, Zhang J (2025) Methicillin-resistant staphylococcus aureus (MRSA): resistance, prevalence, and coping strategies. Antibiotics 14(8):771 Article PubMed PubMed Central CAS Google Scholar Abavisani M, Fazeli E, Ebadpour N, Karav S, Kesharwani P, Sahebkar A (2025) The road less traveled: unexplored targets in the quest for antibiotics against Pseudomonas aeruginosa . Biotechnol Adv 83:108621. https://doi.org/10.1016/j.biotechadv.2025.108621 Article PubMed CAS Google Scholar Abavisani M, Khoshrou A, Khayami R, Kesharwani P, Sahebkar A (2025) Preclinical evaluation of repositioned non-antibiotic agents against Staphylococcus aureus : a network meta-analysis of survival outcomes. World Journal of Microbiology & Biotechnology 41(12):480. https://doi.org/10.1007/s11274-025-04705-z Article Google Scholar ECDC (2022) European Centre for Disease Prevention and Control (ECDC), Surveillance report, Antimicrobial consumption in the EU/EEA (ESAC-Net). https://www.ecdc.europa.eu/sites/default/files/documents/AER-antimicrobial-consumption.pdf ; accessed on 30 March 2024 Mestrovic T, Aguilar GR, Swetschinski LR, Ikuta KS, Gray AP, Weaver ND, Han C, Wool EE, Hayoon AG, Hay SI, Dolecek C (2022) The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis. Lancet Public Health 7(11):e897–e913. https://doi.org/10.1016/S2468-2667(22)00225-0 Article Google Scholar Chatterjee A, Modarai M, Naylor NR, Boyd SE, Atun R, Barlow J, Holmes AH, Johnson A, Robtham JV (2018) Quantifying drivers of antibiotic resistance in humans: a systematic review. Lancet Infect Dis 18:e368–e378. https://doi.org/10.1016/S1473-3099(18)30296-2 Article PubMed CAS Google Scholar Mao X, Yin X, Yang Y, Che Y, Xu X, Deng Y, Zhang T (2024) Standardization in global environmental antibiotic resistance genes (ARGs) surveillance. Crit Rev Environ Sci Technol 54(22):1633–1650 Article CAS Google Scholar Schwartz KL, Morris SK (2018) Travel and the spread of drug-resistant bacteria. Curr Infect Dis Rep 20(9):29. https://doi.org/10.1007/s11908-018-0634-9 Article PubMed Google Scholar Adebisi YA (2023) Balancing the risks and benefits of antibiotic use in a globalized world: the ethics of antimicrobial resistance. Glob Health Action 19:27. https://doi.org/10.1186/s12992-023-00930-z Article Google Scholar Majumder MAA, Rahman S, Cohall D, Bharatha A, Singh K, Haque M et al (2020) Antimicrobial stewardship: fighting antimicrobial resistance and protecting global public health. Infect Drug Resist 13:4713–4738. https://doi.org/10.2147/IDR.S290835 Article PubMed PubMed Central CAS Google Scholar Tacconelli E, Sifakis F, Harbarth S, Schrijver R, Mourik M, Voss A et al (2018) Surveillance for control of antimicrobial resistance. Lancet Infect Dis 18:e99–e106. https://doi.org/10.1016/S1473-3099(17)30485-1 Article PubMed Google Scholar Iskandar K, Molinier L, Hallit S, Sartelli M, Hardcastle TC, Haque M et al (2021) Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture. Antimicrob Resist Infect Control 10:63. https://doi.org/10.1186/s13756-021-00931-w Article PubMed PubMed Central Google Scholar Aiesh BM, Nazzal MA, Abdelhaq AI, Abutaha SA, Zyoud SH, Sabateen A (2023) Impact of an antibiotic stewardship program on antibiotic utilization, bacterial susceptibilities, and cost of antibiotics. Sci Rep 13:5040. https://doi.org/10.1038/s41598-023-32329-6 Article PubMed PubMed Central CAS Google Scholar Lee CF, Cowling BJ, Feng S, Aso H, Wu P, Fukuda K et al (2018) Impact of antibiotic stewardship programmes in Asia: a systematic review and meta-analysis. J Antimicrob Chemother 73:844–851. https://doi.org/10.1093/jac/dkx492 Article PubMed PubMed Central CAS Google Scholar Feldstein D, Sloane PD, Feltner C (2018) Antibiotic stewardship programs in nursing homes: a systematic review. J Am Med Dir Assoc 19:110–116. https://doi.org/10.1016/j.jamda.2017.06.019 Article PubMed Google Scholar Lin DM, Koskella B, Lin HC (2017) Phage therapy: an alternative to antibiotics in the age of multi-drug resistance. World J Gastrointest Pharmacol Ther 8:162–173. https://doi.org/10.4292/wjgpt.v8.i3.162 Article PubMed PubMed Central Google Scholar Romero-Calle D, Guimarães Benevides R, Góes-Neto A, Billington C (2019) Bacteriophages as alternatives to antibiotics in clinical care. Antibiotics 8:138. https://doi.org/10.3390/antibiotics8030138 Article PubMed PubMed Central CAS Google Scholar Murugaiyan J, Kumar PA, Rao GS, Iskandar K, Hawser S, Hays JP et al (2022) Progress in alternative strategies to combat antimicrobial resistance: focus on antibiotics. Antibiotics 11:200. https://doi.org/10.3390/antibiotics11020200 Article PubMed PubMed Central CAS Google Scholar Pradipta IS, Forsman LD, Bruchfeld J, Hak E, Alffenaar J-W (2018) Risk factors of multidrug-resistant tuberculosis: a global systematic review and meta-analysis. J Infect 77:469–478. https://doi.org/10.1016/j.jinf.2018.10.004 Article PubMed Google Scholar Xi Y, Zhang W, Qiao R-J, Tang J (2022) Risk factors for multidrug-resistant tuberculosis: a worldwide systematic review and meta-analysis. PLoS One 17:e0270003. https://doi.org/10.1371/journal.pone.0270003 Article PubMed PubMed Central CAS Google Scholar Zhang Y, Yu Y, Fong PSW, Shen J (2023) Addressing unforeseen public health risks via the use of sustainable system and process management. Front Public Health 11:1249277. https://doi.org/10.3389/fpubh.2023.1249277 Article PubMed PubMed Central Google Scholar Wu C, Ye H, Xu M, Zhao X, Zhao X, Li L, Li M, Wei Y, Li Y, Hu B (2025) Occurrence of antibiotics and antibiotic resistance genes at various stages of different aquaculture modes surrounding Tai Lake, China. Front Microbiol 16:1543387. https://doi.org/10.3389/fmicb.2025.1543387 Article PubMed PubMed Central CAS Google Scholar Dadgostar P (2019) Antimicrobial resistance: implications and costs. Infect Drug Resist 12:3903–3910. https://doi.org/10.2147/IDR.S234610 Article PubMed PubMed Central CAS Google Scholar Huemer M, Mairpady Shambat S, Brugger SD, Zinkernagel AS (2020) Antibiotic resistance and persistence—implications for human health and treatment perspectives. EMBO Rep 21:e51034. https://doi.org/10.15252/embr.202051034 Article PubMed PubMed Central CAS Google Scholar Xie W-Y, Shen Q, Zhao FJ (2018) Antibiotics and antibiotic resistance from animal manures to soil: a review. Eur J Soil Sci 69:181–195. https://doi.org/10.1111/ejss.12494 Article Google Scholar Manyi-Loh C, Mamphweli S, Meyer E, Okoh A (2018) Antibiotic use in agriculture and its consequential resistance in environmental sources: potential public health implications. Molecules 23:795. https://doi.org/10.3390/molecules23040795 Article PubMed PubMed Central CAS Google Scholar Van TTH, Yidana Z, Smooker PM, Coloe PJ (2020) Antibiotic use in food animals worldwide, with a focus on Africa: pluses and minuses. J Glob Antimicrob Resist 20:170–177. https://doi.org/10.1016/j.jgar.2019.07.031 Article PubMed Google Scholar de Kraker MEA, Stewardson AJ, Harbarth S (2016) Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050? PLoS Med 13:e1002184. https://doi.org/10.1371/journal.pmed.1002184 Article PubMed PubMed Central Google Scholar Hernando-Amado S, Coque TM, Baquero F, Martínez JL (2019) Defining and combating antibiotic resistance from one health and global health perspectives. Nat Microbiol 4:1432–1442. https://doi.org/10.1038/s41564-019-0503-9 Article PubMed CAS Google Scholar Malik B, Bhattacharyya S (2019) Antibiotic drug-resistance as a complex system driven by socio-economic growth and antibiotic misuse. Sci Rep 9:9788. https://doi.org/10.1038/s41598-019-46078-y Article PubMed PubMed Central CAS Google Scholar Charani E, Holmes A (2019) Antibiotic stewardship—twenty years in the making. Antibiotics 8:7. https://doi.org/10.3390/antibiotics8010007 Article PubMed PubMed Central Google Scholar Zhang C, Fu X, Liu Y, Zhao H, Wang G (2023) Burden of infectious diseases and bacterial antimicrobial resistance in China: a systematic analysis for the global burden of disease study 2019. Lancet Reg Health West Pac 43:100972. https://doi.org/10.1016/j.lanwpc.2023.100972 Article PubMed PubMed Central Google Scholar Renwick M, Mossialos E (2018) What are the economic barriers of antibiotic R&D and how can we overcome them? Expert Opin Drug Discov 13:889–892. https://doi.org/10.1080/17460441.2018.1515908 Article PubMed Google Scholar Årdal C, Balasegaram M, Laxminarayan R, McAdams D, Outterson K, Rex JH et al (2020) Antibiotic development — economic, regulatory and societal challenges. Nat Rev Microbiol 18:267–274. https://doi.org/10.1038/s41579-019-0293-3 Article PubMed CAS Google Scholar Ghosh C, Sarkar P, Issa R, Haldar J (2019) Alternatives to conventional antibiotics in the era of antimicrobial resistance. Trends Microbiol 27:323–338. https://doi.org/10.1016/j.tim.2018.12.010 Article PubMed CAS Google Scholar Coates ARM, Hu Y, Holt J, Yeh P (2020) Antibiotic combination therapy against resistant bacterial infections: synergy, rejuvenation and resistance reduction. Expert Rev Anti Infect Ther 18:5–15. https://doi.org/10.1080/14787210.2020.1705155 Article PubMed CAS Google Scholar McInnes RS, McCallum GE, Lamberte LE, van Schaik W (2020) Horizontal transfer of antibiotic resistance genes in the human gut microbiome. Curr Opin Microbiol 53:35–43. https://doi.org/10.1016/j.mib.2020.02.002 Article PubMed CAS Google Scholar Lerminiaux NA, Cameron ADS (2019) Horizontal transfer of antibiotic resistance genes in clinical environments. Can J Microbiol 65:34–44. https://doi.org/10.1139/cjm-2018-0275 Article PubMed CAS Google Scholar Orlek A, Anjum MF, Mather AE, Stoesser N, Walker AS (2023) Factors associated with plasmid antibiotic resistance gene carriage revealed using large-scale multivariable analysis. Sci Rep 13(1):2500 Article PubMed PubMed Central CAS Google Scholar McMillan EA, Jackson CR, Frye JG (2020) Transferable plasmids of Salmonella enterica associated with antibiotic resistance genes. Front Microbiol 11:562181. https://doi.org/10.3389/fmicb.2020.562181 Article PubMed PubMed Central Google Scholar Li L-G, Zhang T (2023) Plasmid-mediated antibiotic resistance gene transfer under environmental stresses: insights from laboratory-based studies. Sci Total Environ 887:163870. https://doi.org/10.1016/j.scitotenv.2023.163870 Article PubMed CAS Google Scholar Botts RT, Apffel BA, Walters CJ, Davidson KE, Echols RS, Geiger MR et al (2017) Characterization of four multidrug resistance plasmids captured from the sediments of an urban coastal wetland. Front Microbiol. https://doi.org/10.3389/fmicb.2017.01922 Article PubMed PubMed Central Google Scholar Kakoullis L, Papachristodoulou E, Chra P, Panos G (2021) Mechanisms of antibiotic resistance in important Gram-positive and Gram-negative pathogens and novel antibiotic solutions. Antibiotics 10:415. https://doi.org/10.3390/antibiotics10040415 Article PubMed PubMed Central CAS Google Scholar Durão P, Balbontín R, Gordo I (2018) Evolutionary mechanisms shaping the maintenance of antibiotic resistance. Trends Microbiol 26:677–691. https://doi.org/10.1016/j.tim.2018.01.005 Article PubMed CAS Google Scholar Liu W-T, Chen E-Z, Yang L, Peng C, Wang Q, Xu Z et al (2021) Emerging resistance mechanisms for 4 types of common anti-MRSA antibiotics in Staphylococcus aureus : a comprehensive review. Microb Pathog 156:104915. https://doi.org/10.1016/j.micpath.2021.104915 Article PubMed CAS Google Scholar Vestergaard M, Frees D, Ingmer H (2019) Antibiotic Resistance and the MRSA Problem. Microbiol Spectr 7:10.1128/microbiolspec.gpp3-0057–2018. https://doi.org/10.1128/microbiolspec.gpp3-0057-2018 Article PubMed PubMed Central Google Scholar Thakur V, Uniyal A, Tiwari V (2021) A comprehensive review on pharmacology of efflux pumps and their inhibitors in antibiotic resistance. Eur J Pharmacol 903:174151. https://doi.org/10.1016/j.ejphar.2021.174151 Article PubMed CAS Google Scholar Ebbensgaard AE, Løbner-Olesen A, Frimodt-Møller J (2020) The role of efflux pumps in the transition from low-level to clinical antibiotic resistance. Antibiotics 9:855. https://doi.org/10.3390/antibiotics9120855 Article PubMed PubMed Central CAS Google Scholar Nishino K, Yamasaki S, Nakashima R, Zwama M, Hayashi-Nishino M (2021) Function and inhibitory mechanisms of multidrug efflux pumps. Front Microbiol. https://doi.org/10.3389/fmicb.2021.737288 Article PubMed PubMed Central Google Scholar Du D, Wang-Kan X, Neuberger A, van Veen HW, Pos KM, Piddock LJV et al (2018) Multidrug efflux pumps: structure, function and regulation. Nat Rev Microbiol 16:523–539. https://doi.org/10.1038/s41579-018-0048-6 Article PubMed CAS Google Scholar Reis AC, Kolvenbach BA, Nunes OC, Corvini PFX (2020) Biodegradation of antibiotics: the new resistance determinants – part I. New Biotechnol 54:34–51. https://doi.org/10.1016/j.nbt.2019.08.002 Article CAS Google Scholar Yang QE, Walsh TR (2017) Toxin-antitoxin systems and their role in disseminating and maintaining antimicrobial resistance. FEMS Microbiol Rev 41(3):343–353. https://doi.org/10.1093/femsre/fux006 Article PubMed PubMed Central CAS Google Scholar Sonika S, Singh S, Mishra S, Verma S (2025) Toxin-antitoxin systems in bacterial pathogenesis. Heliyon 11(4):e42945. https://doi.org/10.1016/j.heliyon.2025.e42945 Article PubMed PubMed Central Google Scholar Kunnath AP, Suodha Suoodh M, Chellappan DK, Chellian J, Palaniveloo K (2024) Bacterial persister cells and development of antibiotic resistance in chronic infections: an update. Br J Biomed Sci 81:12958. https://doi.org/10.3389/bjbs.2024.12958 Article PubMed PubMed Central Google Scholar den Van Bergh B, Fauvart M, Michiels J (2017) Formation, physiology, ecology, evolution and clinical importance of bacterial persisters. FEMS Microbiol Rev 41(3):219–251. https://doi.org/10.1093/femsre/fux001 Article CAS Google Scholar Church NA, McKillip JL (2021) Antibiotic resistance crisis: challenges and imperatives. Biol 76:1535–1550. https://doi.org/10.1007/s11756-021-00697-x Article CAS Google Scholar Brauner A, Fridman O, Gefen O, Balaban NQ (2016) Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nat Rev Microbiol 14:320–330. https://doi.org/10.1038/nrmicro.2016.34 Article PubMed CAS Google Scholar Valcourt JR, Lemons JM, Haley EM, Kojima M, Demuren OO, Coller HA (2012) Staying alive: metabolic adaptations to quiescence. Cell Cycle 11(9):1680–1696. https://doi.org/10.4161/cc.19879 Article PubMed PubMed Central CAS Google Scholar Harms A, Maisonneuve E, Gerdes K (2016) Mechanisms of bacterial persistence during stress and antibiotic exposure. Science 354(6318):aaf4268. https://doi.org/10.1126/science.aaf4268 Article PubMed CAS Google Scholar Salcedo-Sora JE, Kell DB (2020) A quantitative survey of bacterial persistence in the presence of antibiotics: towards antipersister antimicrobial discovery. Antibiotics 9(8):508. https://doi.org/10.3390/antibiotics9080508 Article PubMed PubMed Central CAS Google Scholar Rahman KMT, Amaratunga R, Butzin XY, Singh A, Hossain T, Butzin NC (2025) Rethinking dormancy: antibiotic persisters are metabolically active, non-growing cells. Int J Antimicrob Agents 65(1):107386. https://doi.org/10.1016/j.ijantimicag.2024.107386 Article PubMed CAS Google Scholar Balaban NQ, Liu J (2019) Evolution under Antibiotic Treatments: Interplay between Antibiotic Persistence, Tolerance, and Resistance. In: Lewis K (ed) Persister Cells and Infectious Disease. Springer, Cham. https://doi.org/10.1007/978-3-030-25241-0_1 Römling U, Balsalobre C (2012) Biofilm infections, their resilience to therapy and innovative treatment strategies. J Intern Med 272(6):541–561. https://doi.org/10.1111/joim.12004 Article PubMed CAS Google Scholar La Rosa R, Johansen HK, Molin S (2022) Persistent bacterial infections, antibiotic treatment failure, and microbial adaptive evolution. Antibiotics (Basel) 11(3):419. https://doi.org/10.3390/antibiotics11030419 Article PubMed PubMed Central CAS Google Scholar Almatroudi A (2025) Biofilm resilience: molecular mechanisms driving antibiotic resistance in clinical contexts. Biology 14(2):165. https://doi.org/10.3390/biology14020165 Article PubMed PubMed Central CAS Google Scholar Baquero F, Martínez JL, F Lanza V, Rodríguez-Beltrán J, Galán JC, San Millán A, Cantón R, Coque TM (2021) Evolutionary pathways and trajectories in antibiotic resistance. Clin Microbiol Rev 34(4):e0005019. https://doi.org/10.1128/CMR.00050-19 Article PubMed PubMed Central CAS Google Scholar Marine JC, Dawson SJ, Dawson MA (2020) Non-genetic mechanisms of therapeutic resistance in cancer. Nat Rev Cancer 20:743–756. https://doi.org/10.1038/s41568-020-00302-4 Article PubMed CAS Google Scholar Balaban NQ (2011) Persistence: mechanisms for triggering and enhancing phenotypic variability. Curr Opin Genet Dev 21(6):768–775. https://doi.org/10.1016/j.gde.2011.10.001 Article PubMed CAS Google Scholar Lewis K (2012) Persister cells: molecular mechanisms related to antibiotic tolerance. Handb Exp Pharmacol 211:121–133. https://doi.org/10.1007/978-3-642-28951-4_8 Article CAS Google Scholar Mahto KU, Kumari S, Das S (2022) Unraveling the complex regulatory networks in biofilm formation in bacteria and relevance of biofilms in environmental remediation. Crit Rev Biochem Mol Biol 57(3):305–332. https://doi.org/10.1080/10409238.2021.2015747 Article PubMed CAS Google Scholar Ramamurthy T, Ghosh A, Chowdhury G, Mukhopadhyay AK, Dutta S, Miyoshi SI (2022) Deciphering the genetic network and programmed regulation of antimicrobial resistance in bacterial pathogens. Front Cell Infect Microbiol 12:952491. https://doi.org/10.3389/fcimb.2022.952491 Article PubMed PubMed Central CAS Google Scholar Kirthika P, Lloren KKS, Jawalagatti V, Lee JH (2023) Structure, substrate specificity and role of Lon protease in bacterial pathogenesis and survival. Int J Mol Sci 24(4):3422. https://doi.org/10.3390/ijms24043422 Article PubMed PubMed Central CAS Google Scholar Kumar A, Alam A, Bharadwaj P, Tapadar S, Rani M, Hasnain SE (2019) Toxin-Antitoxin (TA) Systems in Stress Survival and Pathogenesis. In: Hasnain S, Ehtesham N, Grover S (eds) Mycobacterium Tuberculosis: Molecular Infection Biology, Pathogenesis, Diagnostics and New Interventions. Springer, Singapore. https://doi.org/10.1007/978-981-32-9413-4_15 Hayes F (2003) Toxins-antitoxins: plasmid maintenance, programmed cell death, and cell cycle arrest. Science 301(5639):1496–14969. https://doi.org/10.1126/science.1088157 Article PubMed CAS Google Scholar Unterholzner SJ, Poppenberger B, Rozhon W (2013) Toxin-antitoxin systems: biology, identification, and application. Mob Genet Elem 3(5):e26219. https://doi.org/10.4161/mge.26219 Article CAS Google Scholar Schumacher MA, Piro KM, Xu W, Hansen S, Lewis K, Brennan RG (2009) Molecular mechanisms of HipA-mediated multidrug tolerance and its neutralization by HipB. Science 323(5912):396–401. https://doi.org/10.1126/science.1163806 Article PubMed PubMed Central CAS Google Scholar Edelmann D, Berghoff BA (2022) A shift in perspective: a role for the type I toxin TisB as persistence-stabilizing factor. Front Microbiol 13:871699. https://doi.org/10.3389/fmicb.2022.871699 Article PubMed PubMed Central Google Scholar Bahassi EM, O’Dea MH, Allali N, Messens J, Gellert M, Couturier M (1999) Interactions of CcdB with DNA gyrase. Inactivation of Gyra, poisoning of the gyrase-DNA complex, and the antidote action of CcdA. J Biol Chem 274(16):10936–10944. https://doi.org/10.1074/jbc.274.16.10936 Article PubMed CAS Google Scholar Jolivet-Gougeon A, Bonnaure-Mallet M (2019) Bacterial Persistence in Biofilms and Antibiotics. Antibiotic Drug Resistance. John Wiley & Sons, Ltd, pp 181–210. https://doi.org/10.1002/9781119282549.ch9 Uruén C, Chopo-Escuin G, Tommassen J, Mainar-Jaime RC, Arenas J (2021) Biofilms as promoters of bacterial antibiotic resistance and tolerance. Antibiotics 10:3. https://doi.org/10.3390/antibiotics10010003 Article CAS Google Scholar Yousefi L, Kadkhoda H, Shirmohammadi M, Moaddab SY, Ghotaslou R, Sadeghi J, Somi MH, Rezaee MA, Ganbarov K (2024) Kafil, HS. CRISPR-like sequences association with antibiotic resistance and biofilm formation in Helicobacter pylori clinical isolates. Heliyon Pulcini C, Clerc-Urmes I, Attinsounon CA, Fougnot S, Thilly N (2019) Antibiotic resistance of Enterobacteriaceae causing urinary tract infections in elderly patients living in the community and in the nursing home: a retrospective observational study. J Antimicrob Chemother 74:775–781. https://doi.org/10.1093/jac/dky488 Article PubMed CAS Google Scholar Chambers HF, DeLeo FR (2009) Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 7:629–641. https://doi.org/10.1038/nrmicro2200 Article PubMed PubMed Central CAS Google Scholar Dellit TH, Owens RC, McGowan JE, Gerding DN, Weinstein RA, Burke JP et al (2007) Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44:159–177. https://doi.org/10.1086/510393 Article PubMed Google Scholar Sikkens JJ, van Agtmael MA, Peters EJG, Vandenbroucke-Grauls CMJE, Kramer MHH, de Vet HCW (2016) Assessment of appropriate antimicrobial prescribing: do experts agree? J Antimicrob Chemother 71:2980–2987. https://doi.org/10.1093/jac/dkw207 Article PubMed CAS Google Scholar Baur D, Gladstone BP, Burkert F, Carrara E, Foschi F, Döbele S et al (2017) Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect Dis 17:990–1001. https://doi.org/10.1016/S1473-3099(17)30325-0 Article PubMed Google Scholar Abavisani M, Foroushan SK, Kesharwani P, Sahebkar A (2025) The frontier of health: exploring therapeutic potentials of the microbiome. PharmaNutrition 31:100435. https://doi.org/10.1016/j.phanu.2025.100435 Article CAS Google Scholar Pontali E, Raviglione MC, Migliori GB (2019) Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives. Eur Respir Rev. https://doi.org/10.1183/16000617.0035-2019 Article PubMed PubMed Central Google Scholar Abavisani M, Khoshrou A, Eshaghian S, Karav S, Sahebkar A (2024) Overcoming antibiotic resistance: the potential and pitfalls of drug repurposing. J Drug Target 33(3):341–367. https://doi.org/10.1080/1061186X.2024.2424895 Article PubMed Google Scholar Khawbung JL, Nath D, Chakraborty S (2021) Drug resistant Tuberculosis: a review. Comp Immunol Microbiol Infect Dis 74:101574. https://doi.org/10.1016/j.cimid.2020.101574 Article PubMed CAS Google Scholar Khawcharoenporn T, Chuncharunee A, Maluangnon C, Taweesakulvashra T, Tiamsak P (2018) Active monotherapy and combination therapy for extensively drug-resistant Pseudomonas aeruginosa pneumonia. Int J Antimicrob Agents 52:828–834. https://doi.org/10.1016/j.ijantimicag.2018.09.008 Article PubMed CAS Google Scholar Tyers M, Wright GD (2019) Drug combinations: a strategy to extend the life of antibiotics in the 21st century. Nat Rev Microbiol 17:141–155. https://doi.org/10.1038/s41579-018-0141-x Article PubMed CAS Google Scholar Brill MJE, Kristoffersson AN, Zhao C, Nielsen EI, Friberg LE (2018) Semi-mechanistic pharmacokinetic–pharmacodynamic modelling of antibiotic drug combinations. Clin Microbiol Infect 24:697–706. https://doi.org/10.1016/j.cmi.2017.11.023 Article PubMed CAS Google Scholar Laws M, Shaaban A, Rahman KM (2019) Antibiotic resistance breakers: current approaches and future directions. FEMS Microbiol Rev 43:490–516. https://doi.org/10.1093/femsre/fuz014 Article PubMed PubMed Central CAS Google Scholar García-Beltrán JM, Arizcun M, Chaves-Pozo E (2023) Antimicrobial peptides from photosynthetic marine organisms with potential application in aquaculture. Mar Drugs 21:290. https://doi.org/10.3390/md21050290 Article PubMed PubMed Central CAS Google Scholar Malaekeh-Nikouei B, Fazly Bazzaz BS, Mirhadi E, Tajani AS, Khameneh B (2020) The role of nanotechnology in combating biofilm-based antibiotic resistance. J Drug Deliv Sci Technol 60:101880. https://doi.org/10.1016/j.jddst.2020.101880 Article CAS Google Scholar Hetta HF, Ramadan YN, Al-Harbi AI, Ahmed A, Battah E, Abd Ellah B (2023) Nanotechnology as a promising approach to combat multidrug resistant bacteria: a comprehensive review and future perspectives. Biomedicines 11:413. https://doi.org/10.3390/biomedicines11020413 Article PubMed PubMed Central CAS Google Scholar Rabetafika HN, Razafindralambo A, Ebenso B, Razafindralambo HL (2023) Probiotics as antibiotic alternatives for human and animal applications. Encyclopedia 3:561–581. https://doi.org/10.3390/encyclopedia3020040 Article Google Scholar Ranjan A (2022) The use of Probiotics, Prebiotics, and synbiotics as an alternative to antibiotics. In: Saha T, Deb Adhikari M, Tiwary BK (eds) Alternatives to antibiotics: recent trends and future prospects. Springer Nature, Singapore, pp 449–465. https://doi.org/10.1007/978-981-19-1854-4_18 Chapter Google Scholar Ouwehand AC, Forssten S, Hibberd AA, Lyra A, Stahl B (2016) Probiotic approach to prevent antibiotic resistance. Ann Med 48:246–255. https://doi.org/10.3109/07853890.2016.1161232 Article PubMed CAS Google Scholar Maldonado Galdeano C, Cazorla SI, Lemme Dumit JM, Vélez E, Perdigón G (2019) Beneficial effects of probiotic consumption on the immune system. Ann Nutr Metab 74:115–124. https://doi.org/10.1159/000496426 Article PubMed CAS Google Scholar Gaspar C, Donders GG, Palmeira-de-Oliveira R, Queiroz JA, Tomaz C, Martinez-de-Oliveira J et al (2018) Bacteriocin production of the probiotic Lactobacillus acidophilus KS400. AMB Express 8:153. https://doi.org/10.1186/s13568-018-0679-z Article PubMed PubMed Central CAS Google Scholar Ozma MA, Moaddab SR, Hosseini H, Khodadadi E, Ghotaslou R, Asgharzadeh M et al (2023) A critical review of novel antibiotic resistance prevention approaches with a focus on postbiotics. Crit Rev Food Sci Nutr 0:1–19. https://doi.org/10.1080/10408398.2023.2214818 Article Google Scholar McCulloch TR, Wells TJ, Souza-Fonseca-Guimaraes F (2022) Towards efficient immunotherapy for bacterial infection. Trends Microbiol 30:158–169. https://doi.org/10.1016/j.tim.2021.05.005 Article PubMed CAS Google Scholar Ramamurthy D, Nundalall T, Cingo S, Mungra N, Karaan M, Naran K et al (2021) Recent advances in immunotherapies against infectious diseases. Immunother Adv 1:ltaa007. https://doi.org/10.1093/immadv/ltaa007 Article PubMed CAS Google Scholar Motley MP, Banerjee K, Fries BC (2019) Monoclonal antibody-based therapies for bacterial infections. Curr Opin Infect Dis 32:210. https://doi.org/10.1097/QCO.0000000000000539 Article PubMed PubMed Central CAS Google Scholar Domenech M, Sempere J, de Miguel S, Yuste J (2018) Combination of antibodies and antibiotics as a promising strategy against multidrug-resistant pathogens of the respiratory tract. Front Immunol. https://doi.org/10.3389/fimmu.2018.02700 Article PubMed PubMed Central Google Scholar Rosini R, Nicchi S, Pizza M, Rappuoli R (2020) Vaccines against antimicrobial resistance. Front Immunol. https://doi.org/10.3389/fimmu.2020.01048 Article PubMed PubMed Central Google Scholar Abavisani M, Khayami R, Hoseinzadeh M, Kodori M, Kesharwani P, Sahebkar A (2023) CRISPR-Cas system as a promising player against bacterial infection and antibiotic resistance. Drug Resist Updat 68:100948. https://doi.org/10.1016/j.drup.2023.100948 Article PubMed CAS Google Scholar Coates ARM, Hu Y (2007) Novel approaches to developing new antibiotics for bacterial infections. Br J Pharmacol 152:1147–1154. https://doi.org/10.1038/sj.bjp.0707432 Article PubMed PubMed Central CAS Google Scholar Clatworthy AE, Pierson E, Hung DT (2007) Targeting virulence: a new paradigm for antimicrobial therapy. Nat Chem Biol 3:541–548. https://doi.org/10.1038/nchembio.2007.24 Article PubMed CAS Google Scholar Talat A, Bashir Y, Khan AU (2022) Repurposing of antibiotics: sense or non-sense. Front Pharmacol 13:833005. https://doi.org/10.3389/fphar.2022.833005 Article PubMed PubMed Central CAS Google Scholar Zheng W, Sun W, Simeonov A (2018) Drug repurposing screens and synergistic drug-combinations for infectious diseases. Br J Pharmacol 175:181–191. https://doi.org/10.1111/bph.13895 Article PubMed CAS Google Scholar Rácz B, Spengler G (2023) Repurposing antidepressants and phenothiazine antipsychotics as efflux pump inhibitors in cancer and infectious diseases. Antibiotics 12:137. https://doi.org/10.3390/antibiotics12010137 Article PubMed PubMed Central CAS Google Scholar Miró-Canturri A, Ayerbe-Algaba R, Smani Y (2019) Drug repurposing for the treatment of bacterial and fungal infections. Front Microbiol 10:41. https://doi.org/10.3389/fmicb.2019.00041 Article PubMed PubMed Central Google Scholar Farha MA, Brown ED (2019) Drug repurposing for antimicrobial discovery. Nat Microbiol 4:565–577. https://doi.org/10.1038/s41564-019-0357-1 Article PubMed CAS Google Scholar Ahmed A, Azim A, Gurjar M, Baronia AK (2014) Current concepts in combination antibiotic therapy for critically ill patients. Indian J Crit Care Med Peer-Rev Off Publ Indian Soc Crit Care Med 18:310–314. https://doi.org/10.4103/0972-5229.132495 Article CAS Google Scholar Yeh Y-C, Huang T-H, Yang S-C, Chen C-C, Fang J-Y (2020) Nano-based drug delivery or targeting to eradicate bacteria for infection mitigation: a review of recent advances. Front Chem 8:286. https://doi.org/10.3389/fchem.2020.00286 Article PubMed PubMed Central CAS Google Scholar Siraj EA, Yayehrad AT, Belete A (2023) How combined macrolide nanomaterials are effective against resistant pathogens? A comprehensive review of the literature. Int J Nanomed 18:5289–5307. https://doi.org/10.2147/IJN.S418588 Article CAS Google Scholar Tang J, Ouyang Q, Li Y, Zhang P, Jin W, Qu S et al (2022) Nanomaterials for delivering antibiotics in the therapy of pneumonia. Int J Mol Sci 23:15738. https://doi.org/10.3390/ijms232415738 Article PubMed PubMed Central CAS Google Scholar Munir MU, Ahmed A, Usman M, Salman S (2020) Recent advances in nanotechnology-aided materials in combating microbial resistance and functioning as antibiotics substitutes. Int J Nanomed 15:7329–7358. https://doi.org/10.2147/IJN.S265934 Article CAS Google Scholar Yang X, Ye W, Qi Y, Ying Y, Xia Z (2021) Overcoming multidrug resistance in bacteria through antibiotics delivery in surface-engineered nano-cargos: recent developments for future nano-antibiotics. Front Bioeng Biotechnol. https://doi.org/10.3389/fbioe.2021.696514 Article PubMed PubMed Central Google Scholar Hochvaldová L, Večeřová R, Kolář M, Prucek R, Kvítek L, Lapčík L et al (2022) Antibacterial nanomaterials: upcoming hope to overcome antibiotic resistance crisis. Nanotechnol Rev 11:1115–1142. https://doi.org/10.1515/ntrev-2022-0059 Article CAS Google Scholar Biswaro LS, da Costa Sousa MG, Rezende TMB, Dias SC, Franco OL (2018) Antimicrobial peptides and nanotechnology, recent advances and challenges. Front Microbiol. https://doi.org/10.3389/fmicb.2018.00855 Article PubMed PubMed Central Google Scholar Tan P, Fu H, Ma X (2021) Design, optimization, and nanotechnology of antimicrobial peptides: from exploration to applications. Nano Today 39:101229. https://doi.org/10.1016/j.nantod.2021.101229 Article CAS Google Scholar Masimen MAA, Harun NA, Maulidiani M, Ismail WIW (2022) Overcoming methicillin-resistance Staphylococcus aureus (MRSA) using antimicrobial peptides-silver nanoparticles. Antibiotics 11:951. https://doi.org/10.3390/antibiotics11070951 Article PubMed PubMed Central CAS Google Scholar Surwade P, Ghildyal C, Weikel C, Luxton T, Peloquin D, Fan X et al (2019) Augmented antibacterial activity of ampicillin with silver nanoparticles against methicillin-resistant Staphylococcus aureus (MRSA). J Antibiot (Tokyo) 72:50–53. https://doi.org/10.1038/s41420111-6 Article PubMed CAS Google Scholar Liao S, Zhang Y, Pan X, Zhu F, Jiang C, Liu Q et al (2019) Antibacterial activity and mechanism of silver nanoparticles against multidrug-resistant Pseudomonas aeruginosa . Int J Nanomedicine 14:1469–1487. https://doi.org/10.2147/IJN.S191340 Article PubMed PubMed Central CAS Google Scholar Ha Gan B, Gaynord J, Rowe M, Deingruber S, Spring TR (2021) The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions. Chem Soc Rev 50:7820–7880. https://doi.org/10.1039/D0CS00729C Article Google Scholar Lima PG, Oliveira JTA, Amaral JL, Freitas CDT, Souza PFN (2021) Synthetic antimicrobial peptides: characteristics, design, and potential as alternative molecules to overcome microbial resistance. Life Sci 278:119647. https://doi.org/10.1016/j.lfs.2021.119647 Article PubMed CAS Google Scholar Bibens L, Becker J-P, Dassonville-Klimpt A, Sonnet P (2023) A review of fatty acid biosynthesis enzyme inhibitors as promising antimicrobial drugs. Pharmaceuticals 16:425. https://doi.org/10.3390/ph16030425 Article PubMed PubMed Central CAS Google Scholar Idrees M, Mohammad AR, Karodia N, Rahman A (2020) Multimodal role of amino acids in microbial control and drug development. Antibiotics 9:330. https://doi.org/10.3390/antibiotics9060330 Article PubMed PubMed Central CAS Google Scholar Sharma D, Garg A, Kumar M, Rashid F, Khan AU (2019) Down-regulation of flagellar, fimbriae, and pili proteins in carbapenem-resistant Klebsiella pneumoniae (NDM-4) clinical isolates: a novel linkage to drug resistance. Front Microbiol. https://doi.org/10.3389/fmicb.2019.02865 Article PubMed PubMed Central Google Scholar Erhardt M (2016) Strategies to block bacterial pathogenesis by interference with motility and chemotaxis. Curr Top Microbiol Immunol 398:185–205. https://doi.org/10.1007/82_2016_493 Article PubMed CAS Google Scholar Dickey SW, Cheung GYC, Otto M (2017) Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance. Nat Rev Drug Discov 16:457–471. https://doi.org/10.1038/nrd.2017.23 Article PubMed PubMed Central CAS Google Scholar Rezzoagli C, Archetti M, Mignot I, Baumgartner M, Kümmerli R (2020) Combining antibiotics with antivirulence compounds can have synergistic effects and reverse selection for antibiotic resistance in Pseudomonas aeruginosa . PLoS Biol 18:e3000805. https://doi.org/10.1371/journal.pbio.3000805 Article PubMed PubMed Central CAS Google Scholar Dehbanipour R, Ghalavand Z (2022) Anti-virulence therapeutic strategies against bacterial infections: recent advances. Germs 12:262–275. https://doi.org/10.18683/germs.2022.1328 Article PubMed PubMed Central CAS Google Scholar Gordillo Altamirano FL, Barr JJ (2019) Phage therapy in the postantibiotic era. Clin Microbiol Rev. https://doi.org/10.1128/cmr.00066-18 Article PubMed PubMed Central Google Scholar Górski A, Międzybrodzki R, Węgrzyn G, Jończyk-Matysiak E, Borysowski J, Weber-Dąbrowska B (2020) Phage therapy: current status and perspectives. Med Res Rev 40:459–463. https://doi.org/10.1002/med.21593 Article PubMed Google Scholar Hatfull GF, Dedrick RM, Schooley RT (2022) Phage therapy for antibiotic-resistant bacterial infections. Annu Rev Med 73:197–211. https://doi.org/10.1146/annurev-med-080219-122208 Article PubMed CAS Google Scholar Schmelcher M, Donovan DM, Loessner MJ (2012) Bacteriophage endolysins as novel antimicrobials. Future Microbiol 7:1147. https://doi.org/10.2217/fmb.12.97 Article PubMed PubMed Central CAS Google Scholar Abavisani M, Hoseinzadeh M, Khayami R, Kodori M, Soleimanpour S, Sahebkar A (2025) Statins, allies against antibiotic resistance? Curr Med Chem 32(4):729–752. https://doi.org/10.2174/0929867331666230829141301 Article PubMed CAS Google Scholar Abavisani M, Keikha M (2023) Global analysis on the mutations associated with multidrug-resistant urogenital mycoplasmas and ureaplasmas infection: a systematic review and meta-analysis. Ann Clin Microbiol Antimicrob 22(1):70. https://doi.org/10.1186/s12941-023-00627-6 Article PubMed PubMed Central Google Scholar Gajic I, Kabic J, Kekic D, Jovicevic M, Milenkovic M, Mitic Culafic D et al (2022) Antimicrobial susceptibility testing: a comprehensive review of currently used methods. Antibiotics 11:427. https://doi.org/10.3390/antibiotics11040427 Article PubMed PubMed Central CAS Google Scholar Van Norman GA (2021) Decentralized clinical trials. JACC: Basic to Translational Science 6:384–387. https://doi.org/10.1016/j.jacbts.2021.01.011 Article PubMed PubMed Central Google Scholar Shlaes DM, Sahm D, Opiela C, Spellberg B (2013) The FDA reboot of antibiotic development. Antimicrob Agents Chemother 57:4605–4607. https://doi.org/10.1128/AAC.01277-13 Article PubMed PubMed Central CAS Google Scholar Krendyukov A, Singhvi S, Zabransky M (2021) Value of adaptive trials and surrogate endpoints for clinical decision-making in rare cancers. Front Oncol 11:636561. https://doi.org/10.3389/fonc.2021.636561 Article PubMed PubMed Central Google Scholar Bhatt DL, Mehta C (2016) Adaptive designs for clinical trials. N Engl J Med 375:65–74. https://doi.org/10.1056/NEJMra1510061 Article PubMed Google Scholar Dartois VA, Rubin EJ (2022) Anti-tuberculosis treatment strategies and drug development: challenges and priorities. Nat Rev Microbiol 20:685–701. https://doi.org/10.1038/s41579-022-00731-y Article PubMed PubMed Central CAS Google Scholar Kerantzas CA, Jacobs WR (2017) Origins of combination therapy for tuberculosis: lessons for future antimicrobial development and application. mBio 8:e01586-16. https://doi.org/10.1128/mBio.01586-16 Article PubMed PubMed Central Google Scholar Yamin D, Uskoković V, Wakil AM, Goni MD, Shamsuddin SH, Mustafa FH et al (2023) Current and future technologies for the detection of Antibiotic-Resistant bacteria. Diagnostics 13:3246. https://doi.org/10.3390/diagnostics13203246 Article PubMed PubMed Central CAS Google Scholar Kaprou GD, Bergšpica I, Alexa EA, Alvarez-Ordóñez A, Prieto M (2021) Rapid methods for antimicrobial resistance diagnostics. Antibiotics 10:209. https://doi.org/10.3390/antibiotics10020209 Article PubMed PubMed Central CAS Google Scholar Wang H, Jia C, Li H, Yin R, Chen J, Li Y et al (2022) Paving the way for precise diagnostics of antimicrobial resistant bacteria. Front Mol Biosci. https://doi.org/10.3389/fmolb.2022.976705 Article PubMed PubMed Central Google Scholar Bordier M, Binot A, Pauchard Q, Nguyen DT, Trung TN, Fortané N et al (2018) Antibiotic resistance in Vietnam: moving towards a one health surveillance system. BMC Public Health 18:1136. https://doi.org/10.1186/s12889-018-6022-4 Article PubMed PubMed Central Google Scholar Wu D, Walsh TR, Wu Y (2021) World Antimicrobial Awareness Week 2021 — spread awareness, stop resistance. China CDC Wkly 3:987–993. https://doi.org/10.46234/ccdcw2021.241 Article PubMed PubMed Central Google Scholar Mathew P, Sivaraman S, Chandy S (2019) Communication strategies for improving public awareness on appropriate antibiotic use: bridging a vital gap for action on antibiotic resistance. J Fam Med Prim Care 8:1867. https://doi.org/10.4103/jfmpc.jfmpc_263_19 Article Google Scholar Suay-García B, Pérez-Gracia MT (2021) Present and Future of Carbapenem-Resistant Enterobacteriaceae Infections. Advances in Clinical Immunology, Medical Microbiology, COVID-19, and Big Data. Jenny Stanford Publishing Google Scholar Tilahun M, Kassa Y, Gedefie A, Ashagire M (2021) Emerging carbapenem-resistant Enterobacteriaceae infection, its epidemiology and novel treatment options: a review. Infect Drug Resist 14:4363–4374. https://doi.org/10.2147/IDR.S337611 Article PubMed PubMed Central CAS Google Scholar Aziz A-M (2013) The role of healthcare strategies in controlling antibiotic resistance. Br J Nurs Mark Allen Publ 22:1066–1074. https://doi.org/10.12968/bjon.2013.22.18.1066 Article Google Scholar Download references Funding This manuscript was prepared without the support of any external funding sources. The authors did not receive any financial assistance or grants to conduct the research or prepare the manuscript for submission. Author information Authors and Affiliations Haitham Abdel-Salam School, Ministry of Education, Al-Jama’at District, Jaramanah, Damascus, Syrian Arab Republic Alissar AlJerf Department of Pharmaceutics, College of Pharmacy, University of Al- Ameed, Karbala City, Iraq Abdullah H. Maad Analytical/Environmental Unit, Department of Pure and Industrial Chemistry, Abia State University, Uturu, Nigeria Prince O. Ukaogo Key Laboratory of Organic Industries, Department of Chemistry, Faculty of Sciences, Damascus University, Damascus, Syrian Arab Republic Loai Aljerf Department of Mother and Child care, Kekem District Hospital, Kekem, West Region, Cameroon Atem Bethel Ajong Department of Biochemistry, University of Dschang, Dschang, West Region, Cameroon Atem Bethel Ajong Faculty of Pharmacy, Arab International University, Damascus, Syrian Arab Republic Muaaz Alajlani Authors Alissar AlJerf View author publications Search author on: PubMed Google Scholar Abdullah H. Maad View author publications Search author on: PubMed Google Scholar Prince O. Ukaogo View author publications Search author on: PubMed Google Scholar Loai Aljerf View author publications Search author on: PubMed Google Scholar Atem Bethel Ajong View author publications Search author on: PubMed Google Scholar Muaaz Alajlani View author publications Search author on: PubMed Google Scholar Contributions Alissar AlJerf: Conceptualization, Methodology, Resources, Validation, Writing – original draft, Writing – review & editing. Abdullah H. Maad: Investigation, Resources, Software. Prince O. Ukaogo: Conceptualization, Investigation, Writing – review & editing. Loai Aljerf: Investigation, Project administration, Resources, Supervision, Writing – original draft, Writing – review & editing. Atem Bethel Ajong: Resources, Writing – original draft, Writing – review & editing. Muaaz Alajlani: Conceptualization, Funding acquisition, Investigation, Project administration, Supervision, Writing – review & editing. Corresponding authors Correspondence to Loai Aljerf or Muaaz Alajlani . Ethics declarations Ethical Approval The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Consent for Publication All authors have read and approved the final manuscript. Clinical trial number Not applicable. Competing interest The authors declare no competing interests. Additional information Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Rights and permissions Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. Reprints and permissions About this article Cite this article AlJerf, A., Maad, A.H., Ukaogo, P.O. et al. Antimicrobial Armageddon: The Professional Guide to Conquering Antibiotic Resistance. Probiotics & Antimicro. Prot. 18 , 7304–7338 (2026). https://doi.org/10.1007/s12602-026-10928-9 Download citation Received : 08 September 2025 Accepted : 14 January 2026 Published : 20 February 2026 Version of record : 20 February 2026 Issue date : June 2026 DOI : https://doi.org/10.1007/s12602-026-10928-9 Share this article Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy shareable link to clipboard Provided by the Springer Nature SharedIt content-sharing initiative Keywords Drug resistance Anti-infective agent Multidrug resistance Bacteriophage Public health Bacterial infection Profiles Alissar AlJerf View author profile Prince O. Ukaogo View author profile Loai Aljerf View author profile Atem Bethel Ajong View author profile Access this article Log in via an institution Subscribe and save Springer+ from €37.37 /Month Starting from 10 chapters or articles per month Access and download chapters and articles from more than 300k books and 2,500 journals Cancel anytime View plans Buy Now Buy article PDF 39,95 € Price includes VAT (Italy) Instant access to the full article PDF. Institutional subscriptions Advertisement Search Search by keyword or author Search Navigation Find a journal Publish with us Track your research Footer Navigation Discover content Journals A-Z Books A-Z Subjects A-Z Publish with us Journal finder Publish your research Language editing Open access publishing Products and services Our products Librarians Societies Partners and advertisers Our brands Springer Nature Portfolio BMC Palgrave Macmillan Apress Discover Corporate Navigation Your privacy choices/Manage cookies Your US state privacy rights Accessibility statement Terms and conditions Privacy policy Help and support Legal notice Cancel contracts here 80.225.82.168 Not affiliated © 2026 Springer Nature